Clinical Trial Update: Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating an alternative schedule of Velcade (bortezomib), dexamethasone, and liposomal doxorubicin (Doxil) in multiple myeloma. The study was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Doxil (liposomal doxorubicin)
• Velcade (bortezomib)

Snippet

Sponsor: Accelerated Community Oncology Research Network | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2012-04-05